Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Harris

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Alcoholism, Clinical and Experimental Research|August 15, 2017
Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine AcetylationMohammed A Assiri, Samantha R Roy, Peter S Harris, et al.
Particle and Fibre Toxicology|February 5, 2025
Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiologyArthur D Stem, Cole R Michel, Peter S Harris, et al.
Redox Biology|January 23, 2021
Cystathionine γ-lyase promotes estrogen-stimulated uterine artery blood flow via glutathione homeostasisRachael Bok, Damian D Guerra, Ramón A Lorca, et al.
Proteomics. Clinical Applications|June 26, 2024
Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin-Fixed Paraffin-Embedded TissueStefanie K Schwab, Peter S Harris, Cole Michel, et al.
Alcohol (Fayetteville, N.Y.)|December 19, 2021
Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarkerPeter S Harris, Cole R Michel, Youngho Yun, et al.
Free Radical Biology & Medicine|August 5, 2019
Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant responseColin T Shearn, Blair Fennimore, David J Orlicky, et al.
Journal of Proteome Research|January 16, 2019
Quantifying Competition among Mitochondrial Protein Acylation Events Induced by Ethanol MetabolismHadi R Ali, Mohammed A Assiri, Peter S Harris, et al.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Alcoholism, Clinical and Experimental Research|August 15, 2017
Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine AcetylationMohammed A Assiri, Samantha R Roy, Peter S Harris, et al.
Particle and Fibre Toxicology|February 5, 2025
Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiologyArthur D Stem, Cole R Michel, Peter S Harris, et al.
Redox Biology|January 23, 2021
Cystathionine γ-lyase promotes estrogen-stimulated uterine artery blood flow via glutathione homeostasisRachael Bok, Damian D Guerra, Ramón A Lorca, et al.
Proteomics. Clinical Applications|June 26, 2024
Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin-Fixed Paraffin-Embedded TissueStefanie K Schwab, Peter S Harris, Cole Michel, et al.
Alcohol (Fayetteville, N.Y.)|December 19, 2021
Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarkerPeter S Harris, Cole R Michel, Youngho Yun, et al.
Free Radical Biology & Medicine|August 5, 2019
Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant responseColin T Shearn, Blair Fennimore, David J Orlicky, et al.
Journal of Proteome Research|January 16, 2019
Quantifying Competition among Mitochondrial Protein Acylation Events Induced by Ethanol MetabolismHadi R Ali, Mohammed A Assiri, Peter S Harris, et al.
Oncotarget|July 25, 2016
Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaEric W Prince, Ilango Balakrishnan, Monil Shah, et al.
Pageof 3